Lisa Go
Internal Medicine · Temple, TXNPI 1184683492
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 9.2% — the pattern of someone who eats at a lot of different presentations.
Across 45 payments — averaging $103.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$430
- Daiichi Sankyo Inc.$359
- AstraZeneca$331
- Agios Pharmaceuticals, Inc.$254
- Astellas Pharma US Inc$250
- Gilead$249
- plus $3K from 23 others
What the payments were for
- Food & beverage$4,653100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 4 | $430 |
| Daiichi Sankyo Inc. | 3 | $359 |
| AstraZeneca | 3 | $331 |
| Agios Pharmaceuticals, Inc. | 2 | $254 |
| Astellas Pharma US Inc | 2 | $250 |
| Gilead(2 entities) | 2 | $249 |
| GSK | 2 | $238 |
| Ipsen Biopharmaceuticals, Inc | 2 | $224 |
| Seagen Inc. | 2 | $214 |
| Johnson & Johnson | 2 | $180 |
| Bayer | 2 | $160 |
| E.r. Squibb & Sons, L.L.C. | 2 | $128 |
| Jazz Pharmaceuticals Inc. | 1 | $122 |
| Regeneron | 1 | $120 |
| Apellis Pharmaceuticals, Inc. | 1 | $119 |
| Sanofi | 1 | $114 |
| Genentech USA, Inc. | 1 | $113 |
| Eisai Inc. | 1 | $113 |
| Genentech, Inc. | 1 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $106 |
| Pfizer | 1 | $103 |
| Genmab U.S., Inc. | 1 | $102 |
| EMD Serono, Inc. | 1 | $101 |
| Geron Corporation | 1 | $101 |
| Regeneron Healthcare Solutions, Inc. | 1 | $94 |
| Rigel Pharmaceuticals, Inc. | 1 | $70 |
| Janssen Scientific Affairs, LLC | 1 | $63 |
| Stemline Therapeutics Inc. | 1 | $51 |
| Beone Medicines USA, Inc. | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,653 in reported general payments places this provider in the 85th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Temple
- Hameed AliTemple$773K
- Catherine McNealTemple$187K
- Timothy MillerTemple$146K
- Michael VolkTemple$65K
- Spencer BerthelsenSugar Land$891K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.